Category: NYSELLY
-
SA Roundtable: Are Eli Lilly and Novo Nordisk overvalued? (NYSE:LLY)
•
jetcityimage Eli Lilly shares (New York Stock Exchange: LLY) and Novo Nordisk (NVO) in recent months, driven by growing demand for the companies’ weight-loss/diabetes drugs tirzepatide, also known as Mounjaro and Zepbound, and semaglutide, known as Ozempic and Wegovy. more Over the past 12 months, Lilly shares are up 76%…
-
SA Roundtable: Are Eli Lilly and Novo Nordisk overvalued? (NYSE:LLY)
•
jetcityimage Eli Lilly shares (New York Stock Exchange: LLY) and Novo Nordisk (NVO) in recent months, driven by growing demand for the companies’ weight-loss/diabetes drugs tirzepatide, also known as Mounjaro and Zepbound, and semaglutide, known as Ozempic and Wegovy. more Over the past 12 months, Lilly shares are up 76%…